Nettleton Joyce A, Brouwer Ingeborg A, Geleijnse Johanna M, Hornstra Gerard
ScienceVoice Consulting, Denver, CO, USA.
Ann Nutr Metab. 2017;70(1):26-33. doi: 10.1159/000455681. Epub 2017 Jan 27.
At a workshop to update the science linking saturated fatty acid (SAFA) consumption with the risk of coronary heart disease (CHD) and ischemic stroke, invited participants presented data on the consumption and bioavailability of SAFA and their functions in the body and food technology. Epidemiological methods and outcomes were related to the association between SAFA consumption and disease events and mortality. Participants reviewed the effects of SAFA on CHD, causal risk factors, and surrogate risk markers. Higher intakes of SAFA were not associated with higher risks of CHD or stroke apparently, but studies did not take macronutrient replacement into account. Replacing SAFA by cis-polyunsaturated fatty acids was associated with significant CHD risk reduction, which was confirmed by randomized controlled trials. SAFA reduction had little direct effect on stroke risk. Cohort studies suggest that the food matrix and source of SAFA have important health effects.
在一次更新将饱和脂肪酸(SAFA)摄入与冠心病(CHD)及缺血性中风风险相关联的科学知识的研讨会上,受邀参与者展示了关于SAFA的摄入、生物利用度及其在人体和食品技术中的功能的数据。流行病学方法和结果与SAFA摄入和疾病事件及死亡率之间的关联有关。参与者回顾了SAFA对冠心病、因果风险因素和替代风险标志物的影响。显然,较高的SAFA摄入量与冠心病或中风的较高风险无关,但研究未考虑宏量营养素替代情况。用顺式多不饱和脂肪酸替代SAFA与显著降低冠心病风险相关,这一点已得到随机对照试验的证实。减少SAFA对中风风险几乎没有直接影响。队列研究表明,SAFA的食物基质和来源具有重要的健康影响。